Position in ABBV
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$5,244,932
+$690,692 QoQ
Shares Held
20,843
-0.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.33%
of 13F equity value
Holder Rank
#1,281
of 4,153 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026LEE DANNER & BASS INC holds $56,269,792 across 8 Drug Manufacturers - General names. ABBV ranks #4 (9.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
102,191 | $25,953,448 | |
| 2 | MRK |
Merck & Co., Inc.
|
89,248 | $11,468,368 | |
| 3 | AMGN |
Amgen Inc
|
21,832 | $7,905,803 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
20,843 | $5,244,932 | |
| 5 | PFE |
Pfizer Inc
|
89,551 | $2,156,388 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
31,718 | $1,827,591 | |
| 7 | NVS |
Novartis AG
|
6,340 | $993,604 | |
| 8 | LLY |
ELI LILLY & Co
|
600 | $719,658 |
All Filings in ABBV
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,244,932 | 20,843 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $4,554,240 | 20,940 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $4,766,301 | 20,860 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $4,465,480 | 19,286 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $3,631,840 | 19,566 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $4,126,077 | 19,693 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $3,475,278 | 19,557 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $3,434,769 | 17,393 | Shares | Sole | 2024-10-30 | |
| 2024-06-30 | $3,053,742 | 17,804 | Shares | Sole | 2024-07-30 | |
| 2023-12-31 | $2,768,384 | 17,864 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $2,769,385 | 18,579 | Shares | Sole | 2023-10-27 | |
| 2023-06-30 | $2,414,226 | 17,919 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $2,946,113 | 18,486 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $2,987,522 | 18,486 | Shares | Sole | 2023-02-01 | |
| 2022-09-30 | $2,409,472 | 17,953 | Shares | Sole | 2022-10-31 | |
| 2022-06-30 | $2,740,491 | 17,893 | Shares | Sole | 2022-07-25 | |
| 2022-03-31 | $2,909,712 | 17,949 | Shares | Sole | 2022-04-27 | |
| 2021-12-31 | $2,445,730 | 18,063 | Shares | Sole | 2022-01-27 | |
| 2021-09-30 | $1,948,455 | 18,063 | Shares | Sole | 2021-11-01 | |
| 2021-06-30 | $1,831,301 | 16,258 | Shares | Sole | 2021-07-27 | |
| 2021-03-31 | $1,759,440 | 16,258 | Shares | Sole | 2021-04-29 | |
| 2020-12-31 | $1,737,758 | 16,218 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $1,407,396 | 16,068 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $1,197,599 | 12,198 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $962,813 | 12,637 | Shares | Sole | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||